SCHEMBL8637

SCHEMBL8637

CC(C)(O)C(C)(C)OBO

nearest known ligand 0.30

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
THRB P10828 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6225184 0.92
Cyclopentene SCHEMBL123234 0.82
Pyridine SCHEMBL16876648 0.80 TSHR (0.36)
SCHEMBL880119 0.78 THRB (0.32) THRB
Pyrazole SCHEMBL18549509 0.76
SCHEMBL2735487 0.75 THRB (0.30) THRB
SCHEMBL9962950 0.73
SCHEMBL20461856 0.73
SCHEMBL20718226 0.73
SCHEMBL14102441 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 3730 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4594306-A1 SYNTHESIS METHODS AND INTERMEDIATES FOR THE PRODUCTION OF REMIBRUTINIB Novartis AG (CH) 2025-08-06 EP claimed
EP-4570796-A1 METHOD FOR PRODUCING MACROLIDE COMPOUND Eisai R&D Management Co., Ltd. (JP) 2025-06-18 EP claimed
WO-2025049604-A1 INHIBITORS OF SOLUTE CARRIER FAMILY 6A MEMBER 19 (SLC6A19) AND METHODS OF USE THEREOF MAZE THERAPEUTICS, INC. (US) 2025-03-06 WO claimed
WO-2024263819-A2 BORON-CONTAINING COMPOUNDS AND METHODS OF PREPARATION AND APPLICATIONS THEREOF THE TRUSTEES OF BOSTON COLLEGE (US) 2024-12-26 WO claimed
CN-118994216-A 2-Boron ester-norbornene and use thereof and polymer containing alkenyl boron ester in main chain 北京大学 2024-11-22 CN claimed
US-20240382457-A1 BIARYL DERIVATIVES AS YAP/TAZ-TEAD PROTEIN-PROTEIN INTERACTION INHIBITORS NOVARTIS PHARMA AG (CH) 2024-11-21 US claimed
US-20240279225-A1 COMPOUNDS AND METHODS FOR THERANOSTIC TARGETING OF PARP ACTIVITY BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2024-08-22 US claimed
EP-4397655-A1 BICYCLIC FUSED RING DERIVATIVE OR SALT THEREOF AND PHARMACEUTICAL COMPOSITION COMPRISING SAME Yuhan Corporation (KR) 2024-07-10 EP claimed
CN-118215659-A Process for producing a solid-state image sensor 组装生物科学股份有限公司 2024-06-18 CN claimed
WO-2024101298-A1 METHOD FOR PRODUCING MACROLIDE COMPOUND エーザイ・アール・アンド・ディー・マネジメント株式会社 2024-05-16 WO claimed
US-20090163486-A1 Novel 2-arylthiazole-4-carboxamide derivatives, their preparation and use as pharmaceuticals BAYER INTELLECTUAL PROPERTY GMBH (DE) 2009-06-25 US claimed
US-20090149517-A1 NOVEL 2-SUBSTITUTED TIAZOLE-4-CARBOXAMIDE DERIVATIVES, THEIR PREPARATION AND USE AS PHARMACEUTICALS BAYER INTELLECTUAL PROPERTY GMBH (DE) 2009-06-11 US claimed
WO-2009052145-A1 THIENOPYRIMIDINE AND PYRAZOLOPYRIMIDINE COMPOUNDS AND THEIR USE AS MTOR KINASE AND PI3 KINASE INHIBITORS WYETH (US) 2009-04-23 WO claimed
US-20090098086-A1 THIENOPYRIMIDINE AND PYRAZOLOPYRIMIDINE COMPOUNDS AND THEIR USE AS MTOR KINASE AND PI3 KINASE INHIBITORS WYETH (US) 2009-04-16 US claimed
WO-2008056257-A2 NOVEL TRIAZINEDIONE DERIVATIVES AS GABA-B RECEPTOR MODULATORS ADDEX PHARMA S.A (CH) 2008-05-15 WO claimed
US-20060009646-A1 Novel organic molecular catalyst having binaphthol skeketon and processes for producing the same and application thereof MEIJI SEIKA KAISHA LTD. (JP) 2006-01-12 US claimed
EP-1178049-B1 Process for the preparation of cephalosporin compounds and intermediates for the synthesis of these compounds PFIZER (US) 2005-12-28 EP claimed
US-20050165229-A1 Novel process PFIZER, INC. (US) 2005-07-28 US claimed
US-20020058806-A1 Novel process ZOETIS SERVICES LLC 2002-05-16 US claimed
EP-1178049-A1 Process for the preparation of cephalosporin compounds and intermediates for the synthesis of these compounds PFIZER INC. (US) 2002-02-06 EP claimed